PD-L1 immunohistochemistry assay concordance in urothelial carcinoma of the bladder and hypopharyngeal squamous cell carcinoma

PD-L1 immunohistochemistry is used to guide treatment decisions regarding the use of checkpoint immunotherapy in the management of urothelial carcinoma of the bladder and hypopharyngeal squamous cell carcinoma. With increasing PD-L1 testing options, a need has arisen to assess the analytical compara...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Surg Pathol
Main Authors: Hodgson, Anjelica, Slodkowska, Elzbieta, Jungbluth, Achim, Liu, Stanley K., Vesprini, Danny, Enepekides, Danny, Higgins, Kevin, Katabi, Nora, Xu, Bin, Downes, Michelle R.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6750743/
https://ncbi.nlm.nih.gov/pubmed/29750666
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PAS.0000000000001084
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados